{"id":"https://openalex.org/W2993847643","doi":"https://doi.org/10.12659/msm.918411","title":"Comparison of Regorafenib, Fruquintinib, and TAS-102 in Previously Treated Patients with Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis of Five Clinical Trials","display_name":"Comparison of Regorafenib, Fruquintinib, and TAS-102 in Previously Treated Patients with Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis of Five Clinical Trials","publication_year":2019,"publication_date":"2019-12-02","ids":{"openalex":"https://openalex.org/W2993847643","doi":"https://doi.org/10.12659/msm.918411","mag":"2993847643","pmid":"https://pubmed.ncbi.nlm.nih.gov/31790382","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6909918"},"language":"en","primary_location":{"id":"doi:10.12659/msm.918411","doi":"https://doi.org/10.12659/msm.918411","is_oa":true,"landing_page_url":"https://doi.org/10.12659/msm.918411","pdf_url":"https://medscimonit.com/download/index/idArt/918411","source":{"id":"https://openalex.org/S156858864","display_name":"Medical Science Monitor","issn_l":"1234-1010","issn":["1234-1010","1643-3750"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320062","host_organization_name":"International Scientific Information Inc.","host_organization_lineage":["https://openalex.org/P4310320062"],"host_organization_lineage_names":["International Scientific Information Inc."],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Science Monitor","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://medscimonit.com/download/index/idArt/918411","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100379144","display_name":"Jianxin Chen","orcid":"https://orcid.org/0000-0002-0831-5934","observed_orcids":["https://orcid.org/0000-0002-0831-5934"]},"institutions":[{"id":"https://openalex.org/I4210088331","display_name":"Quzhou City People's Hospital","ror":"https://ror.org/004qehs09","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210088331"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jianxin Chen","raw_affiliation_strings":["Department of Medical Oncology, Quzhou People\u2019s Hospital, Quzhou, Zhejiang, China (mainland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Quzhou People\u2019s Hospital, Quzhou, Zhejiang, China (mainland)","institution_ids":["https://openalex.org/I4210088331"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100668358","display_name":"Junhui Wang","orcid":"https://orcid.org/0000-0003-4187-3441","observed_orcids":["https://orcid.org/0000-0003-4187-3441","https://orcid.org/0009-0008-8928-1369"]},"institutions":[{"id":"https://openalex.org/I4210088331","display_name":"Quzhou City People's Hospital","ror":"https://ror.org/004qehs09","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210088331"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junhui Wang","raw_affiliation_strings":["Department of Radiation Oncology, Quzhou People\u2019s Hospital, Quzhou, Zhejiang, China (mainland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Quzhou People\u2019s Hospital, Quzhou, Zhejiang, China (mainland)","institution_ids":["https://openalex.org/I4210088331"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102923832","display_name":"Hai Lan Lin","orcid":"https://orcid.org/0009-0005-6284-6946","observed_orcids":["https://orcid.org/0009-0005-6284-6946"]},"institutions":[{"id":"https://openalex.org/I4210088331","display_name":"Quzhou City People's Hospital","ror":"https://ror.org/004qehs09","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210088331"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hai Lin","raw_affiliation_strings":["Department of Gastroenterology, Quzhou People\u2019s Hospital, Quzhou, Zhejiang, China (mainland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Quzhou People\u2019s Hospital, Quzhou, Zhejiang, China (mainland)","institution_ids":["https://openalex.org/I4210088331"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113560979","display_name":"Yonghai Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120223","display_name":"Fuzhou General Hospital of Nanjing Military Command","ror":"https://ror.org/02pqjgd54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210120223"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yonghai Peng","raw_affiliation_strings":["Department of Oncology, Fuzhou General Hospital, Fuzhou, Fujian, China (mainland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Fuzhou General Hospital, Fuzhou, Fujian, China (mainland)","institution_ids":["https://openalex.org/I4210120223"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100379144"],"corresponding_institution_ids":["https://openalex.org/I4210088331"],"apc_list":null,"apc_paid":null,"fwci":0.2376,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.26085434,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"25","issue":null,"first_page":"9179","last_page":"9191"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9049999713897705},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.9800000190734863},{"id":"https://openalex.org/keywords/fruquintinib","display_name":"fruquintinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/trifluridine-tipiracil","display_name":"trifluridine/tipiracil","score":0.9860000014305115},{"id":"https://openalex.org/keywords/triflumuron","display_name":"triflumuron","score":0.5770000219345093},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.6370000243186951},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.949999988079071},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.746999979019165},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.921999990940094},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.9739999771118164},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7960000038146973},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.722000002861023},{"id":"https://openalex.org/keywords/fatal-adverse-events","display_name":"fatal adverse events","score":0.718999981880188},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.9819801449775696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8722993731498718},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.7276501059532166},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7124549746513367},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7050670385360718},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6474356055259705},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.5828553438186646},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5413538813591003},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5176016092300415},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5020339488983154},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44692322611808777},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.41651687026023865},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4133705496788025},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27916306257247925},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.26611191034317017},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014271","descriptor_name":"Trifluridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014271","descriptor_name":"Trifluridine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.12659/msm.918411","doi":"https://doi.org/10.12659/msm.918411","is_oa":true,"landing_page_url":"https://doi.org/10.12659/msm.918411","pdf_url":"https://medscimonit.com/download/index/idArt/918411","source":{"id":"https://openalex.org/S156858864","display_name":"Medical Science Monitor","issn_l":"1234-1010","issn":["1234-1010","1643-3750"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320062","host_organization_name":"International Scientific Information Inc.","host_organization_lineage":["https://openalex.org/P4310320062"],"host_organization_lineage_names":["International Scientific Information Inc."],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Science Monitor","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5868362","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6909918","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:31790382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31790382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical science monitor : international medical journal of experimental and clinical research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6909918","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6909918/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med Sci Monit","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.12659/msm.918411","doi":"https://doi.org/10.12659/msm.918411","is_oa":true,"landing_page_url":"https://doi.org/10.12659/msm.918411","pdf_url":"https://medscimonit.com/download/index/idArt/918411","source":{"id":"https://openalex.org/S156858864","display_name":"Medical Science Monitor","issn_l":"1234-1010","issn":["1234-1010","1643-3750"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320062","host_organization_name":"International Scientific Information Inc.","host_organization_lineage":["https://openalex.org/P4310320062"],"host_organization_lineage_names":["International Scientific Information Inc."],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Science Monitor","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[{"id":"https://openalex.org/G2323092325","display_name":null,"funder_award_id":"81572452","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2993847643.pdf","grobid_xml":"https://content.openalex.org/works/W2993847643.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W242040007","https://openalex.org/W2069305509","https://openalex.org/W2092861431","https://openalex.org/W2111851685","https://openalex.org/W2113086549","https://openalex.org/W2116922255","https://openalex.org/W2147834058","https://openalex.org/W2154188825","https://openalex.org/W2472847770","https://openalex.org/W2560499218","https://openalex.org/W2576440140","https://openalex.org/W2588681363","https://openalex.org/W2626521088","https://openalex.org/W2754547251","https://openalex.org/W2770004975","https://openalex.org/W2774682757","https://openalex.org/W2810647922","https://openalex.org/W2889646458","https://openalex.org/W2890089396","https://openalex.org/W2921396883","https://openalex.org/W2931045841","https://openalex.org/W2955718369","https://openalex.org/W3022903699","https://openalex.org/W3122692944","https://openalex.org/W4324262440","https://openalex.org/W4399625654"],"related_works":["https://openalex.org/W2995212992","https://openalex.org/W7222541852","https://openalex.org/W2955718369","https://openalex.org/W7221679885","https://openalex.org/W4410821741","https://openalex.org/W7123062579","https://openalex.org/W2599484388","https://openalex.org/W4410822681","https://openalex.org/W2770004975","https://openalex.org/W4323045481"],"abstract_inverted_index":{"BACKGROUND":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,12,24,62],"conduct":[5],"a":[6,114,182],"systematic":[7],"review":[8,50],"of":[9,31,186,202],"the":[10,26,54,80,85,125,200],"literature":[11,49],"identify":[13,63],"key":[14],"randomized":[15,65],"controlled":[16,66],"clinical":[17],"trials":[18,67],"(RCTs),":[19],"followed":[20],"by":[21],"network":[22,110,218],"meta-analysis,":[23],"compare":[25],"efficacy":[27],"and":[28,34,57,79,101,128,148,176,212,230,248],"safety":[29],"profiles":[30],"regorafenib,":[32,174,211],"fruquintinib,":[33,175,210],"TAS-102":[35,158,191],"in":[36,159,199],"previously":[37],"treated":[38],"patients":[39,123,160],"with":[40,138,157,161,181,190,225,233,239,246],"metastatic":[41],"colorectal":[42],"carcinoma":[43],"(mCRC).":[44],"MATERIAL":[45],"AND":[46],"METHODS":[47],"Systematic":[48],"was":[51,136,165,179,195,223,237],"performed":[52],"using":[53,109],"Medline,":[55],"Embase,":[56],"Cochrane":[58],"library":[59],"online":[60],"databases":[61],"published":[64],"(RCTs).":[68],"Hazard":[69],"ratios":[70,82],"(HRs)":[71],"for":[72,84,141,228,243],"progression-free":[73],"survival":[74,77],"(PFS),":[75],"overall":[76],"(OS),":[78],"odds":[81],"(ORs)":[83],"objective":[86],"response":[87],"rate":[88,92],"(ORR),":[89],"disease":[90],"control":[91],"(DCR),":[93],"adverse":[94,98,103],"events":[95,99,104],"(AEs),":[96],"serious":[97],"(SAEs),":[100],"fatal":[102],"(FAEs)":[105],"were":[106,129],"compared":[107,156,189,232,245],"indirectly":[108],"meta-analysis":[111,219],"based":[112],"on":[113],"random-effects":[115],"model.":[116],"RESULTS":[117],"Five":[118],"RCTs":[119],"that":[120,134,221],"included":[121],"2,604":[122],"fulfilled":[124],"eligibility":[126],"criteria":[127],"analyzed.":[130],"Indirect":[131],"comparisons":[132],"showed":[133,220],"fruquintinib":[135,222,236],"associated":[137,180,224,238],"significant":[139,167,197,226],"superiority":[140,227],"PFS":[142,229],"(HR,":[143],"0.57;":[144],"95%":[145,152],"CI,":[146,153],"0.34-0.95)":[147],"DCR":[149,231],"(OR,":[150],"1.80;":[151],"1.08-3.01)":[154],"when":[155,188],"mCRC.":[162],"However,":[163],"there":[164],"no":[166,196],"difference":[168,198],"between":[169,173,209],"OS":[170],"or":[171,192,204],"ORR":[172],"TAS-102.":[177,213,249],"Fruquintinib":[178],"significantly":[183,240],"higher":[184],"risk":[185,201,242],"SAEs":[187,244],"regorafenib.":[193],"There":[194],"AEs":[203],"FAEs":[205],"following":[206],"indirect":[207],"comparison":[208],"CONCLUSIONS":[214],"The":[215],"findings":[216],"from":[217],"TAS-102,":[234],"but":[235],"increased":[241],"regorafenib":[247]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-12-13T00:00:00"}